Inventor · disambiguated record
Marielle Chiron-Blondel
Also filed as: CHIRON-BLONDEL MARIELLE
4 granted patents·8 pending applications·14 citations·filing 2005–2021
71Inventor score
Top patents by PatentIndex Score
12 records- 0181US8388963B2Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofVRIGNAUD PATRICIA·Filed 2009·Granted Mar 5, 2013·7 cites·14 claims
- 0277US10501523B2IL-8 level based method of predicting the outcome of colon cancer treatmentSANOFI SA·Filed 2017·Granted Dec 10, 2019·4 cites·10 claims
- 0375US7851443B2Combination comprising combretastatin and anticancer agentsAVENTIS PHARMA SA·Filed 2008·Granted Dec 14, 2010·3 cites·7 claims
- 0464US11208461B2Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancerSANOFI SA·Filed 2019·Granted Dec 28, 2021·0 cites·10 claims
- 0559US2021293821A1Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer by measuring the level of a plasma biomarkerSANOFI SA·Filed 2021·Application pending·0 cites
- 0653US2013184205A1Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereofREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 0753US2019275147A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2019·Application pending·0 cites
- 0853US2006178305A1Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 0952US2014127202A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2014·Application pending·0 cites
- 1049US2018113134A1Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer by measuring the level of a plasma biomarkerSANOFI SA·Filed 2017·Application pending·0 cites
- 1149US2011054035A1Combination Comprising Combretastatin and Anticancer AgentsAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
- 1243US2010160233A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marielle Chiron-Blondel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →